Anti-IL-5 therapy in patients with severe eosinophilic asthma – clinical efficacy and possible criteria for treatment response

被引：0

作者：

Nora Drick

Benjamin Seeliger

Tobias Welte

Jan Fuge

Hendrik Suhling

机构：

[1] Hannover Medical School,Department of Respiratory Medicine

[2] Biomedical Research in End-Stage and Obstructive Lung Disease Hannover (BREATH),undefined

[3] Member of the German Centre for Lung Research (DZL),undefined

来源：

BMC Pulmonary Medicine | / 18卷

关键词：

Severe eosinophilic asthma; Mepolizumab; Treatment response; IL-5; Lung function;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 175 条

[61]

Nelsen LM(undefined)undefined undefined undefined undefined-undefined

[62]

FitzGerald JM(undefined)undefined undefined undefined undefined-undefined

[63]

Bleecker ER(undefined)undefined undefined undefined undefined-undefined

[64]

Nair P(undefined)undefined undefined undefined undefined-undefined

[65]

Korn S(undefined)undefined undefined undefined undefined-undefined

[66]

Ohta K(undefined)undefined undefined undefined undefined-undefined

[67]

Lommatzsch M(undefined)undefined undefined undefined undefined-undefined

[68]

Ortega HG(undefined)undefined undefined undefined undefined-undefined

[69]

Yancey SW(undefined)undefined undefined undefined undefined-undefined

[70]

Mayer B(undefined)undefined undefined undefined undefined-undefined